Andreas Zimmer

Prof. Andreas Zimmer

Department for Pharmaceutical Technology and Biopharmacy, University of Graz, Graz, Austria
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
SWS. Weber
S. Weber
Andreas ZimmerAndreas Zimmer
Andreas Zimmer
JPJ. Pardeike
J. Pardeike

9 January 2020 in Beilstein Journal of Nanotechnology
Verified
Journal Article
Open access
PDF file
IRIvana Ruseska
Ivana Ruseska
Andreas ZimmerAndreas Zimmer
Andreas Zimmer
In today’s modern era of medicine, macromolecular compounds such as proteins, peptides and nucleic acids are dethroning small molecules as leading therapeutics. Given their immense potential, they are highly sought after. However, their application is limited mostly due to their poor in vivo stability, limited cellular uptake and insufficient target specificity. Cell-penetrating peptides (CPPs) represent a major breakthrough for the transport of macromolecules. They have been shown to successfully deliver proteins, peptides, siRNAs and pDNA in different cell types. In general, CPPs are basic peptides with a positive charge at physiological pH. They are able to translocate membranes and gain entry to the cell interior. Nevertheless, the mechanism they use to enter cells still remains an unsolved piece of the puzzle. Endocytosis and direct penetration have been suggested as the two major mechanisms used for internalization, however, it is not all black and white in the nanoworld. Studies have shown that several CPPs are able to induce and shift between different uptake mechanisms depending on their concentration, cargo or the cell line used. This review will focus on the major internalization pathways CPPs exploit, their characteristics and regulation, as well as some of the factors that influence the cellular uptake mechanism.

1 January 2005 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
JWJörg Weyermann
Jörg Weyermann
DLDirk Lochmann
Dirk Lochmann
Andreas ZimmerAndreas Zimmer
Andreas Zimmer

1 August 1995 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
Andreas ZimmerAndreas Zimmer
Andreas Zimmer
JKJörg Kreuter
Jörg Kreuter

1 February 2016 in Journal of Controlled Release
Verified
Journal Article
Closed access
KHKarl Hörmann
Karl Hörmann
Andreas ZimmerAndreas Zimmer
Andreas Zimmer

1 March 2009 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
DRDaniela Reischl
Daniela Reischl
Andreas ZimmerAndreas Zimmer
Andreas Zimmer